A study analyzing relationship between the prognostic nutritional index (PNI) and its variations and efficacy of anlotinib in advanced non-small-cell lung cancer patients
Latest Information Update: 25 Apr 2022
At a glance
- Drugs Catequentinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 25 Apr 2022 New trial record
- 01 Apr 2022 Results published in the Journal of Clinical Laboratory Analysis